UPDATED FEB 2013 ELTP Due Diligence Investor Info

New Post Public Reply Private Reply Replies (0) Message Board
junewong

UPDATED FEB 2013 ELTP Due Diligence Investor Info


Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products and developing generic versions of controlled release drug products with high barriers to entry. Elite has five commercial products with five additional products under review, pending approval by the FDA.

Elite’s lead pipeline products include abuse resistant opioids utilizing the Company’s patented proprietary technology, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse.

Elite also has partnered with Mikah Pharma to develop a new product, with Hi-Tech Pharmacal to develop an intermediate for a generic product, and a Hong Kong based company to develop a branded product for the United States market and its territories.

Elite operates a FDA GMP(Good Manufacturing Practices) and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.








Link to 11 Billion dollar NYSE company - ACT- Actavis Labs distributing ELTP’s Phendimetrazine

http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=84198




Link to product pipeline:

http://www.elitepharma.com/product_pipeline.asp






Link to SEC filings:

http://investing.money.msn.com/investments/se...ymbol=ELTP

Recent PR's:

http://www.elitepharma.com/investor_relations.asp

12/13/2012 ELITE PHARMACEUTICALS, INC. ANNOUNCES AGREEMENT FOR SUPPLY OF PHENTERMINE ACTIVE INGREDIENT


11/14/2012 Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal 2013
...Revenues from new products continue to grow


PATENTS:

Since our incorporation, we have secured eight United States patents of which two have been assigned for a fee to Celgene Corporation for pulsed delivery of methylphenidate. Elite’s patents are:
PATENTS
U.S. patent 5,871,776
U.S. patent 5,902,632
U.S. patent 5,837,284 (assigned to Celgene Corporation)
U.S. patent 6,620,439
U.S. patent 6,635,284 (assigned to Celgene Corporation)
U.S. patent 6,926,909
U.S. patent 6,984,402
U.S. patent 8,182,836
We also have pending applications for four additional U.S. patents and four foreign patents. The pending patent applications are for an opioid agonist and antagonist products that Elite is developing to be used with controlled-release Oxycodone and other opioids to minimize the abuse potential for the opioids.




CEO Funding

Ceo Jerry Treppel personally invested 1 million dollars of his own money in 2 $500,000 non-dilutive financings to keep the research and products sales increases on target.


Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has amended the bridge loan agreement ("Loan Agreement") with Jerry Treppel, Elite's Chairman & CEO. Pursuant to the amendment to the Loan Agreement, Mr. Treppel has agreed to increase the maximum principal amount of the line of credit from $500,000 to $1,000,000. All other terms remain the same. The additional proceeds will be used primarily for working capital to support Elite's increase in production and growth of sales.
A copy of the amendment to the Loan Agreement will be filed in a Current Report on Form 8-K which will be filed with the Securities and Exchange Commission.

http://ih.advfn.com/p.php?pid=nmona&article=55384279


Outstanding shares :

As of November 8, 2012 the issuer had outstanding 350,337,260 shares of common stock

Transfer Agent:


American Stock Transfer & Trust Company, LLC.
6201 15th Avenue
Brooklyn, NY 11219

Phone: 800-937-5449
Fax: 718-236-2641
E Mail: info@amstock.com

Investor Relations Contact:

Dianne Will
(201) 367-7889
E Mail: dianne@elitepharma.com


http://www.elitepharma.com/ir_contact_us.asp

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Aristocrat Interactive Rolls Out iLottery in Michigan

Updated Category News Views 8

You'd think by now everything that could be rolled out in the gambling world has been. But nope, Aristocrat Interactive just proved us wrong with a move that might shake up the iLottery scene. Picture this: Michigan Lottery, one of the big dogs in the U.S. lottery game, just went live with a full-blown iLottery system courtesy of Aristocrat Interactive, and that deserves...

Continue Reading
Why BofA Believes the iPhone 16 Cycle Stands Out

Updated Category News Views 258

Understanding the Distinctiveness of the iPhone 16 Cycle According to analysts from Bank of America, the iPhone 16 cycle presents a significant shift from previous product iterations. This transformation is largely attributed to Apple’s focus on evolving its software through the integration of the new Apple Intelligence platform. Insights from BofA on Apple's Strategy...

Continue Reading
Cheniere Energy Predicts Major Surge in China's Gas Demand

Updated Category News Views 76

Cheniere Energy's Bold Prediction for China's Natural Gas Future Cheniere Energy (NYSE: LNG) has made an eye-opening prediction regarding China's natural gas demand, suggesting an increase to more than 600 billion cubic meters by 2040. This expansion represents a significant leap from the current demand level of about 400 bcm. This expectation was shared during the recent...

Continue Reading
Investing in CPA Careers to Enhance Public Sector Services

Updated Category News Views 43

Understanding the Public Sector Accountant Shortage There's a growing concern regarding the shortage of accounting professionals in the public sector, particularly in state and local governments. This shortage is causing significant challenges in maintaining essential financial services, including the preparation of crucial financial information by staff CPAs and...

Continue Reading
The Growth Journey of Nova: 15 Years of Strong Returns

Updated Category News Views 172

Investing in Nova: A Compelling Story Nova (NASDAQ: NVMI) has made a significant impact in the investment realm over the past 15 years, outperforming market expectations by an impressive margin. With an annualized return of 28.22%, investors who placed their trust in this company have reaped significant rewards. Currently, Nova boasts a market capitalization of...

Continue Reading